ArticleJournal of cellular and molecular medicine2022

Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting the JAK2/STAT3 signalling pathway.

Cai-Lian Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.